Category Archives: Top Market News

Northland Securities Sticks to Their Buy Rating for Viewray (VRAY)

In a report released today, Suraj Kalia from Northland Securities maintained a Buy rating on Viewray (VRAY – Research Report), with a price target of $5. The company’s shares closed last Monday at $4.50. Kalia commented: “We remain confident in

The President & CEO of Clovis Oncology (NASDAQ: CLVS) is Buying Shares

Today, the President & CEO of Clovis Oncology (CLVS – Research Report), Patrick Mahaffy, bought shares of CLVS for $279.6K. Following this transaction Patrick Mahaffy’s holding in the company was increased by 5.74% to a total of $5.18 million. In

Analysts Offer Insights on Healthcare Companies: Nucana Plc (NASDAQ: NCNA), Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) and Trillium Therapeutics (NASDAQ: TRIL)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nucana Plc (NCNA – Research Report), Entasis Therapeutics Holdings Inc (ETTX – Research Report) and Trillium Therapeutics (TRIL – Research Report). Nucana Plc (NCNA) H.C.

InspireMD (NSPR) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on InspireMD (NSPR – Research Report) today and set a price target of $5. The company’s shares closed last Monday at $2.22, close to its 52-week low of $1.90. Bernardino noted:

Adverum Biotechnologies (ADVM) Gets a Hold Rating from Chardan Capital

Chardan Capital analyst Gbola Amusa reiterated a Hold rating on Adverum Biotechnologies (ADVM – Research Report) today and set a price target of $10. The company’s shares closed last Monday at $13.40. According to TipRanks.com, Amusa is a 5-star analyst

Analysts Are Bullish on These Healthcare Stocks: Cumberland Pharmaceuticals Inc (CPIX), Seres Therapeutics (MCRB)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cumberland Pharmaceuticals Inc (CPIX – Research Report), Seres Therapeutics (MCRB – Research Report) and Galapagos NV (GLPG – Research Report) with bullish